Xiaoqing Shi

Antitumor Activity of HKI-272, an Orally Active, Irreversible Inhibitor of the HER-2 Tyrosine Kinase

Sridhar K. Rabindran, Carolyn Discafani, Edward Rosfjord et al. · Cancer Research · 2004 · 638 citations · Full text

Medicine, Oncology, Pharmacology +13

Optimization of 6,7-Disubstituted-4-(arylamino)quinoline-3-carbonitriles as Orally Active, Irreversible Inhibitors of Human Epidermal Growth Factor Receptor-2 Kinase Activity

Hwei‐Ru Tsou, Elsebe G. Overbeek-Klumpers, William Hallett et al. · Journal of Medicinal Chemistry · 2005 · 299 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

Synthesis and Structure−Activity Relationships of 6,7-Disubstituted 4-Anilinoquinoline-3-carbonitriles. The Design of an Orally Active, Irreversible Inhibitor of the Tyrosine Kinase Activity of the Epidermal Growth Factor Receptor (EGFR) and the Human Epidermal Growth Factor Receptor-2 (HER-2)

Allan Wissner, Elsebe Overbeek, Marvin F. Reich et al. · Journal of Medicinal Chemistry · 2002 · 266 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

Generation of SO3−and OH radicals in SO32− reactions with inorganic environmental pollutants and its implications to SO32−toxicity

Xiaoqing Shi · Journal of Inorganic Biochemistry · 1994 · 169 citations

Natural Sciences, Chemistry, Environmental Sciences +16

Stress-induced Inhibition of ERK1 and ERK2 by Direct Interaction with p38 MAP Kinase

Hong Zhang, Xiaoqing Shi, Maggie Hampong et al. · Journal of Biological Chemistry · 2001 · 166 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +15